Complications of subspecialty ophthalmic care: endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor medications (Q38261103)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Complications of subspecialty ophthalmic care: endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor medications	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 September 2017

1 reference

Europe PubMed Central

Complications of subspecialty ophthalmic care: endophthalmitis after intravitreal injections of anti-vascular endothelial growth factor medications (English)

1 reference

Europe PubMed Central

1 September 2017

0 references

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25325851%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Luis J Haddock

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25325851%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

David J Ramsey

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25325851%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

0 references

publication date

1 September 2014

1 reference

Europe PubMed Central

1 September 2017

Seminars in Ophthalmology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25325851%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25325851%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

5-6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25325851%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

257-262

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25325851%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Use of retinal procedures in medicare beneficiaries from 1997 to 2007.

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Delayed-onset bleb-associated endophthalmitis (1996-2008): causative organisms and visual acuity outcomes

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Bacterial dispersal associated with speech in the setting of intravitreous injections.

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Is the use of topical antibiotics for intravitreal injections the standard of care or are we better off without antibiotics?

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Povidone-iodine contact time and lid speculum use during intravitreal injection

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Bimanual assisted eyelid retraction technique for intravitreal injections

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Avastin doesn't blind people, people blind people

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2014.959616

21 January 2018

Identifiers

10.3109/08820538.2014.959616

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25325851%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25325851%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38261103&oldid=1750989322"